Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Innovative Dosing Schedules of AmBisome for Treatment of Experimental Invasive Pulmonary Aspergillosis: Establishing a Preclinical Foundation for Improved Patient Care and Outcome Grant uri icon

Overview

date/time interval

  • July 1, 2022 - February 22, 2024

sponsor award ID

  • SRA 223608-01